16th Annual CME Symposium
This advanced CME activity will provide participants with state-of-the-art information and practical guidance on progress in managing HIV, hepatitis B, and hepatitis C, including drug development and treatment, management of important comorbidities and drug-drug interactions, enabling practitioners to deliver the highest quality care in all practice settings.
The primary goals of this activity are to increase each participant’s competence to:
- Summarize current approaches to achieving a cure for HIV infection
- Identify the optimal antiretroviral management options for
patients with HIV and newer therapies in development
- Illustrate advances in the approach to prevention of HIV infection
- Recognize factors important for assessing risk for cardiovascular disease and
options for preventing cardiovascular morbidities
- Demonstrate the opportunities and challenges of treating addicted patients
- Detail the current treatment options for management of patients with
HBV or HCV and newer therapies now in development
- Explain how to recognize, avoid and manage drug-drug interactions
- Describe developments and controversies in HCV-infected organ transplantation
The curriculum offered at this activity is designed to meet the needs of Infectious Disease Physicians, Hepatologists, Gastroenterologists, Family Physicians, Nurse Practitioners, Physician Assistants, Nurses, Pharmacists, and others involved in frontline HIV and Hepatitis patient care and treatment.
This CME activity is made possible, in part, by educational grants provided or pledged by: